Real-world use of IBI305, a bevacizumab biosimilar, in a tertiary caner-specialized hospital in China [0.03%]
IBI305（一种贝伐单抗生物类似药）在中国一家三级肿瘤专科医院的实际应用
Zhe Chen,Yanting Wang,Jun Yang et al.
Zhe Chen et al.
What is known and objective: To investigate and describe the real-world use of IBI305, a biosimilar of bevacizumab, across all approved indications in the first 12 months since its entry in National cancer center of China...
Observational Study
Journal of clinical pharmacy and therapeutics. 2022 Dec;47(12):2274-2278. DOI:10.1111/jcpt.13809 2022
Optimal exposure to docetaxel in adjuvant chemotherapy for early-stage breast cancer [0.03%]
早期乳腺癌辅助化疗中多西他赛的最优暴露量
Jujiang Guo,Weijie Lin,Yiyin Weng et al.
Jujiang Guo et al.
What is known and objective: Drug-induced neutropenia is the main reason for the dose limitation of docetaxel in patients with breast cancer. The area under the drug concentration-time curve (AUC) of docetaxel is associat...
Asparaginase-related diabetic ketoacidosis: Analysis of the FDA Adverse Event Reporting System (FAERS) data and literature review [0.03%]
与天冬酰胺酶有关的糖尿病酮症酸中毒：FDA不良事件报告系统（FAERS）数据和文献分析
Dongxuan Li,Jinghui Gou,Jie Dong et al.
Dongxuan Li et al.
What is known and objective: Diabetic ketoacidosis (DKA) may occur during asparaginase use. However, limited by the study population, the association between asparaginase and DKA has not been elucidated. The purpose of th...
Apatinib plus paclitaxel versus paclitaxel monotherapy for platinum-resistant recurrent ovarian cancer treatment: A retrospective cohort study [0.03%]
阿帕替尼联合紫杉醇对比单用紫杉醇治疗铂类耐药性卵巢癌：一项回顾性队列研究
Aizhi Geng,Hailei Yang,Zhenfeng Wang et al.
Aizhi Geng et al.
What is known and objective: Apatinib, an oral antiangiogenic drug, exerts potential anti-tumour effects on platinum-resistant recurrent ovarian cancer (PROC). This study intended to evaluate the efficacy and safety of ap...
Low-dose febuxostat exhibits a superior renal-protective effect and non-inferior safety profile compared to allopurinol in chronic kidney disease patients complicated with hyperuricemia: A double-centre, randomized, controlled study [0.03%]
与非布司他相比，低剂量别黄嘌呤在并发高尿酸血症的慢性肾脏疾病患者中具有更优的肾保护作用和不相上下的安全性：一项双中心随机对照研究
Na Yang,Bin Cao
Na Yang
What is known and objective: The present study compared the efficacy and safety of low-dose febuxostat versus allopurinol in chronic kidney disease (CKD) patients complicated with hyperuricemia (HUA). ...
Randomized Controlled Trial
Journal of clinical pharmacy and therapeutics. 2022 Dec;47(12):2214-2222. DOI:10.1111/jcpt.13794 2022
Effects of the international economic sanctions on access to medicine of the Iranian people: A systematic review [0.03%]
国际经济制裁对伊朗人民获取药物的影响：系统性回顾
Ali A Asadi-Pooya,Majid Nazari,Nafiseh Mirzaei Damabi
Ali A Asadi-Pooya
Objective: We hypothesized that the international economic sanctions have affected various groups of Iranian people and have compromised their right to access medicines. ...
Test performance of self-report adherence tools in patients with hypertension: A systematic review and a meta-analysis [0.03%]
系统评价和荟萃分析：高血压患者自我报告的依从性评估工具的有效性测试
Mohammed Khaled Al-Alaili,Abdikarim Mohamed Abdi,Bilgen Basgut
Mohammed Khaled Al-Alaili
What is known and objectives: Adherence has proved to have a positive influence on achieving plausible treatment outcomes. Self-report questionnaires are widely used in evaluating adherence, creating thus a high-powered r...
The role of the clinical pharmacist in the prevention of drug-induced acute kidney injury in the intensive care unit [0.03%]
临床药师在重症监护病房预防药物引起的急性肾损伤的作用
Eyup Can Polat,Alparslan Koc,Kutay Demirkan
Eyup Can Polat
What is known and objective: Acute kidney injury (AKI) is a disorder that is commonly seen in patients in the intensive care unit (ICU) and has a detrimental impact on the patients' clinical prognosis. Although a variety ...
Bilateral toxic epithelial keratopathy following instillation of expired topical eye drops [0.03%]
使用过期眼药水后引起的双侧中毒性上皮角膜炎
Huda AlGhadeer,Abdullah AlHumaidan
Huda AlGhadeer
What is known and objective: Toxic corneal epitheliopathies are common, but the majority are probably so mild that they are subclinical. Clinically significant epithelial keratopathy can occur following a single drop of t...
Influence of CYP3A4*22 and CYP3A5*3 combined genotypes on tacrolimus dose requirements in Egyptian renal transplant patients [0.03%]
CYP3A4*22和CYP3A5*3联合基因型对埃及肾移植患者他克莫司剂量需求的影响
Abdel-Hameed Ibrahim Mohamed Ebid,Dina Ahmed Ismail,Neama M Lotfy et al.
Abdel-Hameed Ibrahim Mohamed Ebid et al.
Background: Tacrolimus is a widely prescribed immunosuppressant agent for kidney transplantation. However, optimal dosing is challenging due to its narrow therapeutic index, potentially serious adverse effects, and wide i...
Observational Study
Journal of clinical pharmacy and therapeutics. 2022 Dec;47(12):2255-2263. DOI:10.1111/jcpt.13804 2022